Primary Culture of Homozygote and Wild-Type Corneal Fibroblasts
暂无分享,去创建一个
S. Kang | Seung-Il Choi | E. K. Kim | Hanna Y. Kim | Tae-im Kim | D. Lee | E. Kim | Seung-Il Choi
[1] C. Nam,et al. Prevalence of Granular Corneal Dystrophy Type 2 (Avellino Corneal Dystrophy) in the Korean Population , 2010, Ophthalmic epidemiology.
[2] Xiongwei Zhu,et al. Mitochondrial Dynamics in Alzheimer’s Disease , 2010, Drugs & aging.
[3] H. Lee,et al. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. , 2009, The American journal of pathology.
[4] J. Olzmann,et al. Corneal Dystrophy-associated R124H Mutation Disrupts TGFBI Interaction with Periostin and Causes Mislocalization to the Lysosome* , 2009, The Journal of Biological Chemistry.
[5] T. Chan,et al. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. , 2009, Cardiovascular research.
[6] Terry Kim,et al. Comparison of corneal deposits after LASIK and PRK in eyes with granular corneal dystrophy type II. , 2008, Journal of refractive surgery.
[7] S. J. Kang,et al. Deposits of Transforming Growth Factor-β-Induced Protein in Granular Corneal Dystrophy Type II After LASIK , 2008, Cornea.
[8] V. Mootha,et al. mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.
[9] W. Craigen,et al. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death , 2007, Nature Cell Biology.
[10] J. P. McCoy,et al. The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity* , 2006, Journal of Biological Chemistry.
[11] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[12] D. Sabatini,et al. Growing roles for the mTOR pathway. , 2005, Current opinion in cell biology.
[13] R. D. Stulting,et al. Avellino corneal dystrophy after LASIK. , 2004, Ophthalmology.
[14] D. Schreiner,et al. The intra-mitochondrial cytochrome c distribution varies correlated to the formation of a complex between VDAC and the adenine nucleotide translocase: this affects Bax-dependent cytochrome c release. , 2004, Biochimica et biophysica acta.
[15] E. Thiel,et al. The K+ channel openers diazoxide and NS1619 induce depolarization of mitochondria and have differential effects on cell Ca2+ in CD34+ cell line KG-1a. , 2003, Experimental hematology.
[16] A. Wagner,et al. A clinical, histopathological, and genetic study of Avellino corneal dystrophy in British families , 2003, Journal of medical genetics.
[17] P. Boelle,et al. Clinical outcome of eight BIGH3-linked corneal dystrophies. , 2002, Ophthalmology.
[18] Y. Tano,et al. Two patterns of opacity in corneal dystrophy caused by the homozygous BIG-H3 R124H mutation. , 2001, American journal of ophthalmology.
[19] P. Koistinen,et al. Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide , 2000, British journal of haematology.
[20] G. Klintworth. Advances in the molecular genetics of corneal dystrophies. , 1999, American journal of ophthalmology.
[21] J. Matés,et al. Antioxidant enzymes and human diseases. , 1999, Clinical biochemistry.
[22] R. S. Sohal,et al. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] Y. Tano,et al. Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations. , 1998, Investigative ophthalmology & visual science.
[24] J. Enghild,et al. Accumulation of beta ig-h3 gene product in corneas with granular dystrophy. , 1998, The American journal of pathology.
[25] D. Schorderet,et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. , 1997 .
[26] R. Folberg,et al. Avellino corneal dystrophy. Clinical manifestations and natural history. , 1992, Ophthalmology.
[27] C. Teng. Granular dystrophy of the cornea. A histochemical and electron microscopic study. , 1967, American journal of ophthalmology.
[28] A. Hipkiss. Mitochondrial dysfunction, proteotoxicity, and aging: causes or effects, and the possible impact of NAD+-controlled protein glycation. , 2010, Advances in clinical chemistry.
[29] In‐San Kim,et al. TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta. , 2007, The international journal of biochemistry & cell biology.
[30] 김선웅,et al. Homozygous Granular Corneal Dystrophy Type II (Avellino Corneal Dystrophy): Natural History and Progression After Treatment , 2007 .
[31] I. Afanas’ev. Free Radical Mechanisms of Aging Processes Under Physiological Conditions , 2005, Biogerontology.
[32] R. Eagle,et al. Immunolocalization of (cid:98) ig-h3 Protein in 5q31-Linked Corneal Dystrophies and Normal Corneas , 1999 .
[33] W. Benson,et al. Combined granular-lattice ('Avellino') corneal dystrophy. , 1997, Transactions of the American Ophthalmological Society.
[34] L. Madisen,et al. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. , 1992, DNA and cell biology.
[35] R. Folberg,et al. Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families. , 1988, Ophthalmology.